According to a recent labor market analysis report [1], universities, research institutes, and many companies are competing for a limited pool of technicians who can produce cell and gene therapy products. Cell therapy products include immunotherapies, cancer vaccines, and other types of both autologous (self cells ...
Both the Moderna and Pfizer-BioNTech COVID-19 vaccines rely on large networks of suppliers and manufacturers for successfully producing, tracking, and distributing doses. This story follows the production path and careers for the people and companies working to protect us from COVID-19.
